Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) announced the availability of once-daily YOSPRALA, the only prescription fixed-dose combination of aspirin, an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE